首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 2-羟基丁二酸盐(4,6-二甲基嘧啶-5-基)(4-((S)-4-((R)-2-甲氧基-1-(4-(三氟甲基)苯基)乙基)-3-甲基哌嗪-1-基)-4-甲基哌啶-1-基)甲酮

2-羟基丁二酸盐(4,6-二甲基嘧啶-5-基)(4-((S)-4-((R)-2-甲氧基-1-(4-(三氟甲基)苯基)乙基)-3-甲基哌嗪-1-基)-4-甲基哌啶-1-基)甲酮

(4,6-dimethylpyrimidin-5-yl)(4-((S)-4-((R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone 2-hydroxysuccinate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

541503-81-5

中文名称

2-羟基丁二酸盐(4,6-二甲基嘧啶-5-基)(4-((S)-4-((R)-2-甲氧基-1-(4-(三氟甲基)苯基)乙基)-3-甲基哌嗪-1-基)-4-甲基哌啶-1-基)甲酮

英文名称

(4,6-dimethylpyrimidin-5-yl)(4-((S)-4-((R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone 2-hydroxysuccinate

别名

Vicriviroc Malate;1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate;CS-599

标准英文名

(4,6-dimethylpyrimidin-5-yl)(4-((S)-4-((R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone 2-hydroxysuccinate

分子式

C32H44F3N5O7

分子量

667.73

精确分子量

667.32

SMILES

COC[C@@H](C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)C[C@@H]1C.O=C(O)CC(O)C(=O)O

标准SMILES

CC1(CCN(CC1)C(=O)C1C(C)=NC=NC=1C)N1CCN([C@@H](COC)C2C=CC(=CC=2)C(F)(F)F)[C@@H](C)C1.OC(CC(O)=O)C(O)=O

用途

Vicriviroc malate is a potent CCR5 antagonist with an IC50 of 0.91 nM, exhibiting broad-spectrum activity against genetically diverse HIV-1 isolates, including those with RTI, PRI, and MDR phenotypes; it is in Phase 3 clinical development. It inhibits MIP-1α-induced migration of Ba/F3 cells stably expressing recombinant human CCR5 (IC50 = 0.91 nM), suppresses RANTES-induced intracellular calcium release in U-87-CCR5 cells (IC50 = 16 nM), and inhibits GTPγS binding to RANTES-stimulated HTS-hCCR5 cell membranes (IC50 = 4.2 nM). Vicriviroc demonstrates potent antiviral activity against a panel of 30 R5-tropic HIV-1 isolates representing diverse genetic clades, with EC50 values ranging from 0.04 nM to 2.3 nM and EC90 values from 0.45 nM to 18 nM, showing 2- to 40-fold greater potency than SCH-C. It is also highly effective against the Clade G Russian isolate RU570 (EC90 = 16 nM), which is resistant to SCH-C (EC90 > 1 μM). Vicriviroc targets the early stage of the HIV-1 life cycle prior to reverse transcription and virion maturation, and shows no activity against viruses that utilize the CXCR4 coreceptor (R5/X4 or X4-tropic).

InChIKey

HQJIGHNTROUVLT-RIAYWLAYSA-N

安全信息

SureRoute逆合成路线

1.  541503-81-5 逆合成路线 1

—
—
ACCHUI753
541503-81-5
来源: SureRoute

2.  541503-81-5 逆合成路线 2

—
—
ACIRYU804
157335-93-8
ACCHUI753
541503-81-5
来源: SureRoute

3.  541503-81-5 逆合成路线 3

—
—
—
—
ACCHUI753
541503-81-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手